A study in Kyrgyz Republic has found a shorter treatment regimen for multidrug-resistant tuberculosis (MDR-TB) to be effective.
The objective of this analysis was to evaluate treatment outcomes for MDR-TB patients enrolled on treatment with a shorter treatment regimen.
The preliminary results of the study, funded by USAID, have reported 74 percent of the MDR-TB patients have had negative culture results for TB.
Based on the results of this study, a shorter treatment regimen will be introduced in all regions of the country in 2018. The study took place between January and June 2017 in two pilot sites.
After two months of treatment, 60 percent of patients had negative culture results, and 84 percent after six months.
These results are particularly promising as Kyrgyz Republic is one of 25 high MDR-TB burden countries – 26 percent of new and 61 percent of previously treated patients had MDR-TB.
Previously, the treatment outcomes of MDR-TB in the country had been poor, with just 55 percent of patients having successful treatment and 22 percent being lost to follow up in 2014.
Although these are preliminary results, the experience in Kyrgyz Republic shows that short treatment regimen is efficient under programmatic conditions.